ResMed downgraded to Hold

With its price up 25% in a couple of months we're downgrading ResMed to Hold.

When we raised ResMed’s buy price on 21 Nov 14, we noted that earnings would be helped by the Aussie dollar’s fall of almost 10% since June. Well a month later and the fall is up to 13%, which should add another 3–5% to earnings – yet the share price has celebrated with a rise of 13%.


SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

Related Articles